329 related articles for article (PubMed ID: 23286823)
1. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults.
Di Pierro F; Adami T; Rapacioli G; Giardini N; Streitberger C
Expert Opin Biol Ther; 2013 Mar; 13(3):339-43. PubMed ID: 23286823
[TBL] [Abstract][Full Text] [Related]
2. Effect of administration of Streptococcus salivarius K12 on the occurrence of streptococcal pharyngo-tonsillitis, scarlet fever and acute otitis media in 3 years old children.
Di Pierro F; Colombo M; Giuliani MG; Danza ML; Basile I; Bollani T; Conti AM; Zanvit A; Rottoli AS
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4601-4606. PubMed ID: 27874935
[TBL] [Abstract][Full Text] [Related]
3. Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media.
Di Pierro F; Donato G; Fomia F; Adami T; Careddu D; Cassandro C; Albera R
Int J Gen Med; 2012; 5():991-7. PubMed ID: 23233809
[TBL] [Abstract][Full Text] [Related]
4. Use of Streptococcus salivarius K12 to reduce the incidence of pharyngo-tonsillitis and acute otitis media in children: a retrospective analysis in not-recurrent pediatric subjects.
Di Pierro F; Risso P; Poggi E; Timitilli A; Bolloli S; Bruno M; Caneva E; Campus R; Giannattasio A
Minerva Pediatr; 2018 Jun; 70(3):240-245. PubMed ID: 29322750
[TBL] [Abstract][Full Text] [Related]
5. Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children.
Di Pierro F; Colombo M; Zanvit A; Risso P; Rottoli AS
Drug Healthc Patient Saf; 2014; 6():15-20. PubMed ID: 24600248
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Efficacy of BLIS-Producing Probiotic K12 for the Prevention of Group A Streptococcus Pharyngitis: a Short Communication.
Di Pierro F
Probiotics Antimicrob Proteins; 2019 Mar; 11(1):332-334. PubMed ID: 29464500
[TBL] [Abstract][Full Text] [Related]
7. Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study.
Andaloro C; Santagati M; Stefani S; La Mantia I
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):879-887. PubMed ID: 30767047
[TBL] [Abstract][Full Text] [Related]
8. Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A beta-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study.
Jorgensen DM
Clin Microbiol Infect; 2009 Dec; 15(12):1103-10. PubMed ID: 19929975
[TBL] [Abstract][Full Text] [Related]
9. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
Tagg JR
Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154
[TBL] [Abstract][Full Text] [Related]
10. Effect of Oral Probiotic Streptococcus salivarius K12 on Group A Streptococcus Pharyngitis: A Pragmatic Trial in Schools.
Doyle H; Pierse N; Tiatia R; Williamson D; Baker M; Crane J
Pediatr Infect Dis J; 2018 Jul; 37(7):619-623. PubMed ID: 29189607
[TBL] [Abstract][Full Text] [Related]
11. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
12. Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study.
Falck G; Grahn-Håkansson E; Holm SE; Roos K; Lagergren L
Acta Otolaryngol; 1999; 119(8):944-8. PubMed ID: 10728939
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the probiotic Streptococcus salivarius K12 for the treatment and/or prevention of sore throat: a systematic review.
Wilcox CR; Stuart B; Leaver H; Lown M; Willcox M; Moore M; Little P
Clin Microbiol Infect; 2019 Jun; 25(6):673-680. PubMed ID: 30616011
[TBL] [Abstract][Full Text] [Related]
14. Positive clinical outcomes derived from using
Di Pierro F; Colombo M; Zanvit A; Rottoli AS
Drug Healthc Patient Saf; 2016; 8():77-81. PubMed ID: 27920580
[TBL] [Abstract][Full Text] [Related]
15. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adults.
McCarty J; Hernon Y; Linn L; Therasse DG; Molina A; Bleile N
Clin Ther; 1992; 14(1):30-40. PubMed ID: 1576624
[TBL] [Abstract][Full Text] [Related]
16. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.
Burton JP; Chilcott CN; Moore CJ; Speiser G; Tagg JR
J Appl Microbiol; 2006 Apr; 100(4):754-64. PubMed ID: 16553730
[TBL] [Abstract][Full Text] [Related]
17. An Experimental Group A
Rivera-Hernandez T; Carnathan DG; Jones S; Cork AJ; Davies MR; Moyle PM; Toth I; Batzloff MR; McCarthy J; Nizet V; Goldblatt D; Silvestri G; Walker MJ
mBio; 2019 Apr; 10(2):. PubMed ID: 31040243
[TBL] [Abstract][Full Text] [Related]
18. Pharyngitis-tonsillitis in a college population.
Ruch CR; Beckwith DG
J Am Coll Health; 1984 Apr; 32(5):222-6. PubMed ID: 6376585
[No Abstract] [Full Text] [Related]
19. Efficacy of tonsillectomy in treatment of recurrent group A beta-hemolytic streptococcal pharyngitis.
Orvidas LJ; St Sauver JL; Weaver AL
Laryngoscope; 2006 Nov; 116(11):1946-50. PubMed ID: 17075399
[TBL] [Abstract][Full Text] [Related]
20. [Significance of normal oropharyngeal flora in the development of streptococcal pharyngitis and outcome of penicillin therapy].
Mihajlović-Ukropina M; Roncević N
Med Pregl; 1998; 51(5-6):275-8. PubMed ID: 9720358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
